ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Pharming’s APDS drug scores EU orphan status
October 22, 2020Pharming’s investigational treatment for activated phosphoinositide 3-kinase delta syndrome (APDS) has been granted orphan drug designation from the European Commission. -
Setback for Pharming’s bid to expand use of Ruconest
September 27, 2018US regulators have turned down Pharming’s application to expand the approved uses of Ruconest to include prophylaxis... -
Pharming submits supplemental BLA to FDA for Ruconest for prophylaxis of hereditary angioedema attac
November 28, 2017Pharming Group has submitted a supplemental biologics license application to the US FDA for Ruconest for routine prophylaxis to prevent attacks in adult and adolescent patients with hereditary angioedema.
Pharma Sources Insight January 2025
